Yasmin, T, Menon, SN, Pandey, A, Siddiqua, S, Kuddus, SA, Rahman, MM, Khan, F, Hoque, N, Rana, MS, Subhan, N, Habibi, E, Ramezani, F, Sarker, S, Nahar, L, Alam, MA and Hasan, R Resveratrol attenuates hepatic oxidative stress and preserves gut mucosal integrity in high-fat diet-fed rats by modulating antioxidant and anti-inflammatory pathways. Scientific Reports. (Accepted)
![]() |
Text
Resveratrol attenuates hepatic oxidative stress and preserves gut mucosal integrity in high-fat diet-fed rats by modulating antioxidant and anti-inflammatory pathways.pdf - Accepted Version Access Restricted Download (8MB) |
Abstract
This study evaluated the protective effects of resveratrol against high-fat diet (HFD)-induced hepatic dysfunction and intestinal mucus layer depletion with a focus on antioxidant and anti-inflammatory mechanisms. HFD-fed rats were treated with resveratrol for eight weeks, and various metabolic, molecular, and histological parameters were assessed. Resveratrol therapy significantly reduced body weight gain and adiposity, lowered plasma and hepatic oxidative stress markers, and restored endogenous antioxidant enzyme activity. Liver function markers including ALT, AST, and ALP were normalized in treated animals. RT-PCR analysis showed enhanced expression of lipid-metabolizing and antioxidant genes including PPARα, CPT-1, Nrf2, and HO-1. Histological analysis revealed that resveratrol attenuated hepatic steatosis, collagen deposition, and fibrosis. Importantly, it preserved the goblet cell population within both intestinal crypts and villi, thereby maintaining the integrity of the gut-mucus barrier. These findings demonstrate that resveratrol exerts a multi-organ protective effect by simultaneously preserving intestinal mucus, improving hepatic antioxidant defenses, and reducing fibrosis. This study highlights a novel gut–liver axis mechanism for resveratrol action that extends beyond its well-known anti-obesity and mitochondrial benefits.
Item Type: | Article |
---|---|
Subjects: | Q Science > QH Natural history > QH301 Biology R Medicine > R Medicine (General) |
Divisions: | Pharmacy and Biomolecular Sciences |
Publisher: | Nature Research |
Date of acceptance: | 20 June 2025 |
Date of first compliant Open Access: | 23 June 2025 |
Date Deposited: | 23 Jun 2025 13:59 |
Last Modified: | 23 Jun 2025 14:15 |
URI: | https://researchonline.ljmu.ac.uk/id/eprint/26630 |
![]() |
View Item |